MCK - McKesson Corporation
NYSE
->
Healthcare
->
Medical Distribution
Irving,
United States
Type: Equity
MCK price evolution
MCK
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2302 | $4583 | $1982 | |
| Short term investments | ||||
| Net receivables | $25270 | $23743 | $21622 | $23066 |
| Inventory | $24176 | $25571 | $21139 | $22020 |
| Total current assets | $53341 | $52252 | $47970 | $47640 |
| Long term investments | ||||
| Property, plant & equipment | $3856 | $4092 | $4045 | $3880 |
| Goodwill & intangible assets | $12163 | $12242 | $12070 | |
| Total noncurrent assets | $19418 | $19473 | $18872 | |
| Total investments | ||||
| Total assets | $72429 | $71670 | $67443 | $66512 |
| Current liabilities | ||||
| Accounts payable | $53317 | $51704 | $47097 | $46699 |
| Deferred revenue | ||||
| Short long term debt | $347 | $345 | $562 | |
| Total current liabilities | $58771 | $56434 | $52357 | $51661 |
| Long term debt | $5691 | $5584 | $5579 | $7046 |
| Total noncurrent liabilities | $16617 | $16685 | $16533 | |
| Total debt | $7397 | $7390 | $7608 | |
| Total liabilities | $75446 | $73425 | $69414 | $68194 |
| Shareholders' equity | ||||
| Retained earnings | $15959 | $15810 | $14978 | $14268 |
| Other shareholder equity | -$890 | -$913 | -$881 | -$812 |
| Total shareholder equity | -$1755 | -$1971 | -$2053 | |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4583 | $4678 | $3532 | $6278 |
| Short term investments | ||||
| Net receivables | $21622 | $19410 | $18583 | $19181 |
| Inventory | $21139 | $19691 | $18702 | $19246 |
| Total current assets | $47970 | $44292 | $46231 | $45382 |
| Long term investments | ||||
| Property, plant & equipment | $4045 | $3812 | $3640 | $4681 |
| Goodwill & intangible assets | $12242 | $12224 | $11510 | $12371 |
| Total noncurrent assets | $19473 | $18028 | $17067 | $19633 |
| Total investments | ||||
| Total assets | $67443 | $62320 | $63298 | $65015 |
| Current liabilities | ||||
| Accounts payable | $47097 | $42490 | $38086 | $38975 |
| Deferred revenue | ||||
| Short long term debt | $345 | $1267 | $1096 | $1132 |
| Total current liabilities | $52357 | $47957 | $48466 | $44103 |
| Long term debt | $7045 | $6028 | $6446 | $8273 |
| Total noncurrent liabilities | $16685 | $15853 | $16624 | $20737 |
| Total debt | $7390 | $7295 | $7542 | $9405 |
| Total liabilities | $69042 | $63810 | $65090 | $64840 |
| Shareholders' equity | ||||
| Retained earnings | $14978 | $12295 | $9030 | $8202 |
| Other shareholder equity | -$881 | -$905 | -$1534 | -$1480 |
| Total shareholder equity | -$1971 | -$1857 | -$2272 | -$21 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $76355 | $80898 | ||
| Cost of revenue | $72770 | $77746 | ||
| Gross Profit | $3585 | $3152 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2189 | $2506 | ||
| Total operating expenses | $2369 | $2510 | ||
| Operating income | $1216 | $642 | ||
| Income from continuing operations | ||||
| EBIT | $1211 | $635 | ||
| Income tax expense | $340 | -$18 | ||
| Interest expense | $80 | $64 | ||
| Net income | ||||
| Net income | $791 | $589 | ||
| Income (for common shares) | $791 | $589 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $308951 | $276711 | $263966 | $238228 |
| Cost of revenue | $296123 | $264353 | $250836 | $226080 |
| Gross Profit | $12828 | $12358 | $13130 | $12148 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $8657 | $7776 | $10537 | $8849 |
| Total operating expenses | $8919 | $7977 | $11092 | $17188 |
| Operating income | $3909 | $4381 | $2038 | -$5040 |
| Income from continuing operations | ||||
| EBIT | $3883 | $4713 | $1928 | -$5017 |
| Income tax expense | $629 | $905 | $636 | -$695 |
| Interest expense | $252 | $248 | $178 | $217 |
| Net income | ||||
| Net income | $3002 | $3560 | $1114 | -$4539 |
| Income (for common shares) | $3002 | $3560 | $1114 | -$4539 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $915 | $791 | $589 | |
| Operating activities | ||||
| Depreciation | $226 | $202 | $223 | |
| Business acquisitions & disposals | $90 | -$266 | -$9 | |
| Stock-based compensation | ||||
| Total cash flows from operations | -$1380 | $4147 | $254 | |
| Investing activities | ||||
| Capital expenditures | -$167 | -$269 | -$154 | |
| Investments | ||||
| Total cash flows from investing | -$373 | -$87 | -$577 | -$180 |
| Financing activities | ||||
| Dividends paid | -$162 | -$82 | -$82 | -$83 |
| Sale and purchase of stock | -$505 | -$637 | -$821 | |
| Net borrowings | -$226 | $209 | ||
| Total cash flows from financing | -$2408 | -$809 | -$968 | -$622 |
| Effect of exchange rate | $1 | -$5 | $7 | |
| Change in cash and equivalents | -$2074 | -$2281 | $2602 | -$541 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $3002 | $3560 | $1114 | -$4539 |
| Operating activities | ||||
| Depreciation | $863 | $857 | $1001 | $1221 |
| Business acquisitions & disposals | -$225 | $210 | $572 | $365 |
| Stock-based compensation | ||||
| Total cash flows from operations | $4314 | $5159 | $4434 | $4542 |
| Investing activities | ||||
| Capital expenditures | -$687 | -$558 | -$535 | -$641 |
| Investments | ||||
| Total cash flows from investing | -$1072 | -$542 | -$89 | -$415 |
| Financing activities | ||||
| Dividends paid | -$314 | -$292 | -$277 | -$276 |
| Sale and purchase of stock | -$2909 | -$3475 | -$3296 | -$678 |
| Net borrowings | $56 | -$277 | -$1334 | -$540 |
| Total cash flows from financing | -$3342 | -$4368 | -$6321 | -$1693 |
| Effect of exchange rate | $6 | $25 | $55 | -$61 |
| Change in cash and equivalents | -$94 | $744 | -$2461 | $2373 |
News
Fundamentals
| Market cap | $104.18B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 127.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -35.03 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.91 |
| Quick ratio | 0.50 |